09Apr 2023
Validation of miR-31-5p as Azoospermia Biomarker: Impact of Preanalytical Variables

Validation of miR-31-5p as Azoospermia Biomarker: Impact of Preanalytical Variables

Predicting the origin of azoospermia with non‐invasive biomarkers is clinically relevant for determining the chance of successful sperm retrieval from the testes before attempting assisted reproduction treatment. In this study, the semen small extracellular vesicle microRNA miR‐31‐5p‐based biomarker test to distinguish obstructive azoospermia from secretory azoospermia is validated for clinical use. Findings indicate that the use of total seminal plasma as an analytical sample would facilitate the use of a simplified technical procedure for miR‐31‐5p quantification. In addition, it would significantly improve reproductive treatment decision protocols for azoospermia in clinical practice.

  • #urology

Like

Save

Share